This summer, a proposed amendment to the Controlled Substances Act known as the Cooper Davis Act (the “act”) is making its way through congressional approvals and causing growing dissension between and among parents, consumer safety advocates, and anti-drug coalitions on one hand, and the DEA, privacy experts, and constitutional scholars on the other.
As currently